Tag: Parkinson’s Disease

Scientists Score a Breakthrough with Parkinson’s in a Petri Dish

Parkinson's disease (PD) is a relatively rare but devastating condition affecting 1-2% of Americans. Although some risk factors are known -- including genetic variants that predispose to the condition -- its exact causes and mechanisms remain a mystery, and development of treatments has been slow. 23andMe ...

Read more

23andWe Research Update: Something Old and Something New

One of 23andMe’s core missions is to accelerate the pace of scientific research and contribute to our understanding of the genetic basis of human health and traits. Central to this mission is our growing database of genotyped customers who have consented to allow us to incorporate their genetic data and ...

Read more

23andMe and a New Paradigm for Research

As highlighted in Thomas Goetz's new Wired article "Sergey's Search," 23andMe's innovative web-based research platform is pushing Parkinson's disease research ahead at an unprecedented pace.  With our database clocking in at 50,000 genotyped customers—a number that grows everyday—we're poised to make exciting ...

Read more

23andMe Parkinson’s Research Initiative Progress Update

By Nick Eriksson, 23andMe Principal Scientist, and Lizzie Dorfman, Parkinson's Research Project Manager Less than a year ago we announced the launch of the 23andMe Parkinson’s Research Initiative. Since then, we have built one of the world's most useful resources for studying the genetics of Parkinson's ...

Read more

SNPwatch: Genetic Association Study of Leprosy Yields New Insights into an Ancient Disease

Leprosy is a chronic, disabling disease caused by a bacterium (Mycobacterium leprae) that infects only humans and armadillos. The disease affects the skin and peripheral nerves, leading to sores, numbness in the limbs, muscle weakness, and, in severe cases, disfiguring nodules on the skin. Known since ...

Read more

SNPwatch: Common Genetic Variants Associated With Risk for Parkinson’s Disease Identified in Asian and European Populations

PET scans showing dopamine activity in a normal brain and a Parkinson’s patient’s before and after treatment with a therapeutic implant. More than a million Americans have Parkinson’s disease, and another 50,000 are diagnosed each year. Scientists know that many of the characteristic symptoms of ...

Read more

DNA Variation May Help Us Break Free From Our Routines

"But we always go there!" And so begins another Friday night.  When it comes to choosing where to go to dinner, my husband likes to stick with the tried and true. I like trying out new places. A new study suggests that the roots of this conflict could spring partly from our genes. It suggests that a DNA ...

Read more

On Our Way to 10,000: 23andMe Welcomes First Members of Parkinson’s Disease Community

We've set out to build the world's largest online PD genetics community, and we're thrilled to report that more than 2,000 people have enrolled since the initiative was launched last month. Owing to tremendous support from The Parkinson's Institute and Clinical Center and The Michael J. Fox Foundation, their ...

Read more

Understanding The Genetics of Parkinson’s Disease: A Work In Progress

PET scans showing dopamine activity in a normal brain and a Parkinson's patient's before and after treatment with a therapeutic implant. More than a million Americans have Parkinson's disease, and another 50,000 are diagnosed each year. Scientists know that many of the characteristic symptoms of ...

Read more

A New Approach to Research: The 23andMe Parkinson’s Disease Initiative

By 23andMe Co-Founders Linda Avey and Anne Wojcicki We started 23andMe with a simple, yet expansive, vision: to take DNA into the mainstream.  In order to demystify genetics, we thought the best approach was to give individuals access to their genomes and help them gain personalized insight into their own ...

Read more

Return to top